HONG YUAN HOLDING GROUP (HGYN) stock: key figures, P/E, revenue and dividend
Materials · China · ISIN US43859A1097
Price
0.03 USD
Market cap
2.24 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
HONG YUAN HOLDING GROUP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 837,753.00 USD |
| Gross profit | 539,645.00 USD |
| Operating income | 176,478.00 USD |
| EBIT | 170,849.00 USD |
| Net income | 155,329.00 USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About HONG YUAN HOLDING GROUP
Hong Yuan Holding Group does not have significant operations. previously, the company was engaged in the development and commercialization of bio-based resins. The company was formerly known as Cereplast, Inc. and changed its name to Hong Yuan Holding Group in June 2021. Hong Yuan Holding Group was incorporated in 2001 and is based in Zhengzhou, China.
More stocks
- LQR House Inc. (YHC)
- TurnOnGreen, Inc. (TOGI)
- BioXcel Therapeutics, Inc. (BTAI)
- Totaligent, Inc. (TGNT)
- Autonomix Medical, Inc. (AMIX)
- ECO SCIENCE SOLUTIONS, INC. (ESSI)
- CERENOME, INC. (CNSY)
- Decentral Life, Inc. (WDLF)
- Calidi Biotherapeutics, Inc. (CLDI)
- NaturalShrimp Inc (SHMP)
- POWERDYNE INTERNATIONAL, INC. (PWDY)
- REVELATION BIOSCIENCES, INC. (REVB)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.